Nanping Lin
Overview
Explore the profile of Nanping Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Lin N, Zhang S, Weng L, Chen C, Ou W, et al.
Heliyon
. 2024 Aug;
10(15):e34876.
PMID: 39157383
Objective: The difference in the tumor microenvironment (TME) between primary breast cancer (PBC) and breast cancer brain metastasis (BCBM) is still unknown. Herein, we present the landscape of the TME...
2.
Lin N, Wang L, Huang Q, Zhou W, Liu X, Liu J
PLoS One
. 2022 Oct;
17(10):e0276627.
PMID: 36315553
Background: Prophylactic transarterial chemoembolization (p-TACE) is frequently conducted for patients with hepatocellular carcinoma (HCC) in China, but the question of who could benefit from it remains controversial. Hence, we wanted...
3.
Lin N, Li J, Yao X, Zhang X, Liu G, Zhang Z, et al.
Int J Surg
. 2022 Oct;
107:106959.
PMID: 36265780
We aimed to evaluate the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in colorectal cancer liver metastasis (CRLM). A comprehensive search was conducted across PubMed, MedLine, and the Cochrane Library...
4.
Lin N, Li J, Ke Q, Wang L, Cao Y, Liu J
Dis Markers
. 2020 Sep;
2020:4867974.
PMID: 32963635
Aim: To evaluate the prognostic significance of C-reactive protein to albumin ratio (CAR) for clinical outcomes in hepatocellular carcinoma (HCC) patients. Eligible studies were searched by PubMed, MedLine, the Cochrane...
5.
Lin N, Li J, Ke Q, Wang L, Liu J
Int J Surg
. 2020 Jul;
81:158-164.
PMID: 32629031
Background: The intermittent Pringle's maneuver (IPM) is conducted mainly during the procedure of hepatectomy to control intraoperative blood loss (IBL), but it has been questioned since improvement of surgical technology...
6.
Wang L, Lin N, Lin K, Xiao C, Wang R, Chen J, et al.
J Gastrointest Surg
. 2020 May;
25(5):1172-1183.
PMID: 32440804
Background And Aims: Surgical resection for patients with intermediate hepatocellular carcinoma (HCC) is preferred in China, but the prognosis remains far from satisfactory. Postoperative transarterial chemoembolization (p-TACE) has been conducted...
7.
Ke Q, Chen Y, Huang Q, Lin N, Wang L, Liu J
PLoS One
. 2020 May;
15(5):e0232590.
PMID: 32379819
Background: The incidence of a positive microscopic ductal margin (R1) after surgical resection for perihilar cholangiocarcinoma (pCCA) remains high, but the beneficial of additional resection has not been confirmed by...
8.
Lin N, Li J, Ke Q, Xin F, Zeng Y, Wang L, et al.
PLoS One
. 2020 Mar;
15(3):e0229870.
PMID: 32160231
Background And Aim: To evaluate the effect of intermittent pringle maneuver (IPM) on the long-term prognosis and recurrence of hepatocellular carcinoma (HCC). Methods: Eligible studies were identified by PubMed and...
9.
Ke Q, Lin N, Deng M, Wang L, Zeng Y, Liu J
PLoS One
. 2020 Feb;
15(2):e0229292.
PMID: 32084210
Backgroud: Resection is still the only potentially curative treatment for patients with intrahepatic cholangiocarcinoma (ICC), but the prognosis remains far from satisfactory. However, the benefit of adjuvant therapy (AT) remains...
10.
Wang L, Ke Q, Lin N, Huang Q, Zeng Y, Liu J
Int J Hyperthermia
. 2019 Dec;
36(1):1288-1296.
PMID: 31852267
To evaluate the clinical value of transarterial chemoembolization (TACE) combined with microwave ablation (MWA) for unresectable hepatocellular carcinoma (HCC). Eligible studies were identified using PubMed, MedLine, Embase, the Cochrane Library,...